Fibrinogen plasma levels are an independent prognostic parameter in patients with cervical cancer

American Journal of Obstetrics and Gynecology

Volumn 200, Issue 6, 2009, Pages 647.e1-647.e7

  Polterauer, Stephan ^a   Seebacher, Veronika ^a   Hefler Frischmuth, Katrin ^b   Grimm, Christoph ^a,b   Heinze, Georg ^a   Tempfer, Clemens ^a   Reinthaller, Alexander ^a   Hefler, Lukas ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b WILHELMINEN HOSPITAL   (Austria)

Author keywords

cervical cancer; coagulation; fibrinogen; inflammation; prognosis

Indexed keywords

ANTINEOPLASTIC AGENT; FIBRINOGEN;

ADULT; ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; DISEASE ASSOCIATION; DISEASE FREE INTERVAL; DISEASE FREE SURVIVAL; FEMALE; FIBRINOGEN BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HYSTERECTOMY; ITALY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROGNOSIS; UTERINE CERVIX CANCER; UTERINE CERVIX CONIZATION;

FEMALE; FIBRINOGEN; HUMANS; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

EID: 67349219630     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2009.01.008     Document Type: Article

References (31)

1. Tennent G.A., Brennan S.O., Stangou A.J., O'Grady J., Hawkins P.N., and Pepys M.B. Human plasma fibrinogen is synthesized in the liver. Blood 109 (2007) 1971-1974
2. Koenig W. Fibrin(ogen) in cardiovascular disease: an update. Thromb Haemost 89 (2003) 601-609
3. Collen D., Tytgat G.N., Claeys H., and Piessens R. Metabolism and distribution of fibrinogen: I, fibrinogen turnover in physiological conditions in humans. Br J Haematol 22 (1972) 681-700
4. Palumbo J.S., Kombrinck K.W., Drew A.F., et al. Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. Blood 96 (2000) 3302-3309
5. Falanga A., and Rickles F.R. Pathophysiology of the thrombophilic state in the cancer patients. Semin Thromb Hemost 25 (1999) 173-182
6. Gouin-Thibault I., Achkar A., and Samama M.M. The thrombophilic state in cancer patients. Acta Haematol 106 (2001) 33-42
7. Danesh J., Lewington S., et al., Fibrinogen Studies Collaboration. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA 294 (2005) 1799-1809
8. Balkwill F., and Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 357 (2001) 539-545
9. Schacter E., and Weitzman S.A. Chronic inflammation and cancer. Oncology 16 (2002) 217-226
10. Coussens L.M., and Werb Z. Inflammation and cancer. Nature 420 (2002) 860-867
11. Yamashita H., Kitayama J., Kanno N., Yatomi Y., and Nagawa H. Hyperfibrinogenemia is associated with lymphatic as well as hematogenous metastasis and worse clinical outcome in T2 gastric cancer. BMC Cancer 6 (2006) 147
12. Wang Q., Xie R., and Zang Q.Y. Clinical significance of plasma fibrinogen level in patients with colorectal cancer. Zhongua Zhong Liu Za Zhi 27 (2005) 544-546
13. Takeuchi H., Ikeuchi S., Kitagawa Y., et al. Pretreatment plasma fibrinogen level correlates with tumor progression and metastasis in patients with squamous cell carcinoma of the esophagus. J Gastroenterol Hepatol 22 (2007) 2222-2227
14. Preston T., Slater C., McMillan D.C., Falconer J.S., Shenkin A., and Fearon K.C. Fibrinogen synthesis is elevated in fasting cancer patients with an acute phase response. J Nutr 128 (1998) 1355-1360
15. Gocze P.M., Vahrson H.W., and Freeman D.A. Serum levels of squamous cell carcinoma antigen and ovarian carcinoma antigen (CA 125) in patients with benign and malignant diseases of the uterine cervix. Oncology 51 (1994) 430-434
16. Gaarenstroom K.N., Kenter G.G., Bonfrer J.M., et al. Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis?. Gynecol Oncol 77 (2000) 164-170
17. Bolli J.A., Doering D.L., Bosscher J.R., et al. Squamous cell carcinoma antigen: clinical utility in squamous cell carcinoma of the uterine cervix. Gynecol Oncol 55 (1994) 169-173
18. Juang C.M., Wang P.H., Yen M.S., Lai C.R., Ng H.T., and Yuan C.C. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix. Gynecol Oncol 76 (2000) 103-106
19. Sproston A.R., Roberts S.A., Davidson S.E., Hunter R.D., and West C.M. Serum tumour markers in carcinoma of the uterine cervix and outcome following radiotherapy. Br J Cancer 72 (1995) 1536-1540
20. Fujiwaki R., Iida K., Nakayama K., et al. Clinical significance of interleukin-1 receptor antagonist in patients with cervical carcinoma. Gynecol Oncol 89 (2003) 77-83
21. Srivani R., and Nagarajan B. A prognostic insight on in vivo expression of interleukin-6 in uterine cervical cancer. Int J Gynecol Cancer 13 (2003) 331-339
22. Tartour E., Gey A., Sastre-Garau X., Lombard Surin I., Mosseri V., and Fridman W.H. Prognostic value of intratumoral interferon gamma messenger RNA expression in invasive cervical carcinomas. J Natl Cancer Inst 90 (1998) 287-294
23. Garcia-Arias A., Cetina L., Candelaria M., Robles E., and Dueñas-González A. The prognostic significance of leukocytosis in cervical cancer. Int J Gynecol Cancer 17 (2007) 465-470
24. Polterauer S., Grimm C., Tempfer C., et al. C-reactive protein is a prognostic parameter in patients with cervical cancer. Gynecol Oncol 107 (2007) 114-117
25. Clauss A. Rapid physiological coagulation method in determination of fibrinogen. Acta Haematol 17 (1957) 237-246
26. Wenger R.H., Rolfs A., Marti H.H., Bauer C., and Gassmann M. Hypoxia, a novel inducer of acute phase gene expression in a human hepatoma cell line. J Biol Chem 270 (1995) 27865-27870
27. Sahni A., Simpson-Haidaris P.J., Sahni S.K., Vaday G.G., and Francis C.W. Fibrinogen synthesized by cancer cells augments the proliferative effect of fibroblast growth factor-2 (FGF-2). J Thromb Haemost 6 (2008) 176-183
28. Lawrence S.O., and Simpson-Haidaris P.J. Regulated de novo biosynthesis of fibrinogen in extrahepatic epithelial cells in response to inflammation. Thromb Haemost 92 (2004) 234-243
29. Jensen T., Kierulf P., Sandset P.M., et al. Fibrinogen and fibrin induce synthesis of proinflammatory cytokines from isolated peripheral blood mononuclear cells. Thromb Haemost 97 (2007) 822-829
30. Yakovlev S., Zhang L., Ugarova T., and Medved L. Interaction of fibrin(ogen) with leukocyte receptor alpha M beta 2 (Mac-1): further characterization and identification of a novel binding region within the central domain of the fibrinogen gamma-module. Biochemistry 44 (2005) 617-626
31. Krobot K., Hense H.W., Cremer P., Eberle E., and Keil U. Determinants of plasma fibrinogen: relation to body weight, waist-to-hip ratio, smoking, alcohol, age, and sex: results from the second MONICA Augsburg survey 1989-1990. Arterioscler Thromb 12 (1992) 780-788